Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's acquisition of PillPack is hitting traditional pharmacies.
Stocks quotes in this article: CVS, WBA, RAD, AMZN

Amazon.com Inc. (AMZN) is taking over the pharmaceutical retail space.

The company announced its acquisition of PillPack, an online pharmacy, on Thursday, June 28.

The acquisition announcement sent pharmaceutical retailers such as Walgreens Boots Alliance Inc. (WBA) , Rite Aid Corp. (RAD) and CVS Health Corp (CVS) into a tailspin. 

Amazon is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells AMZN? Learn more now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

TAGS: Pharmaceuticals | Retail | United States | Video

More from Video

Conagra Brands Looks Tastier After Its Upgrade to Buy

Bruce Kamich

CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.

Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts

Bruce Kamich

Breaking down an approach to the long side of this biotech stock.

Is Renewable Energy the Defensive Stock Opportunity You're Missing

Kevin Curran

AMSC CEO discusses that and China challenges.

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Kevin Curran

One of pharma's biggest CEO's talks M&A action on the exchange.

Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment

Kevin Curran

Citi overcame a mixed print to send its stock surging on Monday.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight